V.S. Moiseyev

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)

V.S. Moiseyev · European Heart Journal · 2002 · 599 citations · Full text

Medicine, Cardiology, Pharmacology +14

Haemodynamic and clinical effects of ularitide in decompensated heart failure

V. Mitrovic, Petar Seferović, Dejan Simeunović et al. · European Heart Journal · 2006 · 163 citations · Full text

Medicine, Cardiology, Pharmacology +17

Renal effects of ularitide in patients with decompensated heart failure

Hartmut Lüss, Veselin Mitrović, Petar Seferović et al. · American Heart Journal · 2008 · 53 citations

Pharmacy, Cardiology, Pharmacology +14

RUSSLAN STUDY INVESTIGATORS. SAFETY AND EFFICACY OF A NOVEL CALCIUM SENSITIZER, LEVOSIMENDAN, IN PATIENTS WITH LEFT VENTRICULAR FAILURE DUE TO AN ACUTE MYOCARDIAL INFARCTION. A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY (RUSSLAN)

V.S. Moiseyev, Pentti Põder, Nikolajs Andrejevs et al. · 2002 · 50 citations

Medicine, Cardiology, Pharmacology +11

Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. a randomized, placebo-controlled, double-blind study (RUSSLAN)

V.S. Moiseyev, Pentti Põder, Nikolajs Andrejevs · ACC Current Journal Review · 2003 · 19 citations

Medicine, Cardiology, Pharmacology +14